Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

4,048

Participants

Timeline

Start Date

November 9, 2009

Primary Completion Date

January 10, 2011

Study Completion Date

February 1, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

GSK2340274A

One intramuscular injection

BIOLOGICAL

GSK2340273A

One intramuscular injection

Trial Locations (38)

13031

GSK Investigational Site, Camillus

13901

GSK Investigational Site, Binghamton

16506

GSK Investigational Site, Erie

20850

GSK Investigational Site, Rockville

21045

GSK Investigational Site, Columbia

27103

GSK Investigational Site, Winston-Salem

29303

GSK Investigational Site, Spartanburg

32205

GSK Investigational Site, Jacksonville

32720

GSK Investigational Site, DeLand

33484

GSK Investigational Site, Delray Beach

33761

GSK Investigational Site, Clearwater

37203

GSK Investigational Site, Nashville

40509

GSK Investigational Site, Lexington

44094

GSK Investigational Site, Willoughby Hills

60610

GSK Investigational Site, Chicago

64114

GSK Investigational Site, Kansas City

67207

GSK Investigational Site, Wichita

85020

GSK Investigational Site, Phoenix

85028

GSK Investigational Site, Phoenix

85213

GSK Investigational Site, Mesa

90057

GSK Investigational Site, Los Angeles

98801

GSK Investigational Site, Wenatchee

01757

GSK Investigational Site, Milford

08244

GSK Investigational Site, Somers Point

02886

GSK Investigational Site, Warwick

V3K 3P4

GSK Investigational Site, Coquitlam

A0A 1G0

GSK Investigational Site, Bay Roberts

A1A 3R5

GSK Investigational Site, St. John's

L6T 3T1

GSK Investigational Site, Brampton

P3E 1H5

GSK Investigational Site, Greater Sudbury

N5W 6A2

GSK Investigational Site, London

K1Y 4G2

GSK Investigational Site, Ottawa

M3H 5S4

GSK Investigational Site, Toronto

J8Y 6S8

GSK Investigational Site, Gatineau

G1E 7G9

GSK Investigational Site, Québec

G1W 4R4

GSK Investigational Site, Québec

J1H 1Z1

GSK Investigational Site, Sherbrooke

G6W 5M6

GSK Investigational Site, St-Romulad

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00979602 - Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older | Biotech Hunter | Biotech Hunter